Intended for healthcare professionals

  1. News & Views
  2. Sulfonylureas as...
  3. Sulfonylureas as second line treatment for type 2 diabetes
Editorials

Sulfonylureas as second line treatment for type 2 diabetes

BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3041 (Published 18 July 2018) Cite this as: BMJ 2018;362:k3041

Related articles

ResearchSulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events

See more

Cited by...

  • Cardiovascular safety and efficacy of combination therapy with metformin and sodium-glucose cotransporter-2 inhibitors versus metformin and sulfonylureas in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Back to top